2014-2018 U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies This new study from Venture Planning Group contains 408 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Research Beam Model: Research Beam Product ID: 174804 1200 USD New
2014-2018 U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2014-2018 U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

 
 
 

2014-2018 U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies



This new study from Venture Planning Group contains 408 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.



Report Highlights



Market shares of leading suppliers

Business and technological trends in major markets

Five-year test volume and sales forecasts

Market shares of leading competitors

Feature comparison of major analyzers

Strategic profiles of leading market players and start-up firms developing innovative products

Specific product and business opportunities for instrument and consumable suppliers.

Rationale



Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.



U.K. Market Overview



Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment.

Five-year test volume and sales projections.

Market Segmentation Analysis



Five-year test volume and sales projections:



Infectious Diseases Forensic Testing

Cancer Paternity Testing/HLA Typing

Genetic DiseasesOthers

A comprehensive analysis of the sequencing market by laboratory segment.

Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers.

Product/Technology Review



Comparison of the major molecular diagnostic analyzers.

Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.

Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments



Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Abbott

Affymetrix

Agilent Technologies

Applied Gene Technologies

Arca/Nuvelo

Beckman Coulter/Danaher

Becton Dickinson

Biokit

BioMerieux

Bio-Rad

Biotest

Caliper

Cepheid

Decode

Diadexus

Eiken

Enzo

Exact Sciences

Fujirebio/Innogenetics

Grifols

Hologic/Gen-Probe

Illumina

Kreatech

Li-Cor Biosciences

Life Technologies/Thermo Fisher

Monogram Biosciences

Myriad Genetics

Nanogen/Elitech

Orchid CellMark

Ortho-Clinical Diagnostics

Proteome Sciences

Qiagen

Roche

Scienion

Sequenom

Shimadzu

Siemens

Sierra Molecular

Takara Bio

Tecan Group

Comprehensive listings of companies developing and marketing molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations



Specific new product development opportunities with potentially significant market appeal during the next five years.

Design criteria for new products.

Alternative market penetration strategies.

Potential market entry barriers and risks.

Business planning issues and concerns.